If you're interested in Stem cell transplant and/or Cellular Therapy this is the list #bmtsm #CARTcells #leusm #mmsm #lymsm #MedSky #TcellRx go.bsky.app/7xxh8WW
November 22, 2024 at 2:33 PM
If you're interested in Stem cell transplant and/or Cellular Therapy this is the list #bmtsm #CARTcells #leusm #mmsm #lymsm #MedSky #TcellRx go.bsky.app/7xxh8WW
Many thanks to @cudeptofmedicine.bsky.social for featuring our patient-reported outcomes work in this year's Annual Report! #lymsm #medsky #oncsky cc @cuanschutz.bsky.social @cucancercenter.bsky.social @accordsresearch.bsky.social
September 22, 2026 at 8:22 PM
Many thanks to @cudeptofmedicine.bsky.social for featuring our patient-reported outcomes work in this year's Annual Report! #lymsm #medsky #oncsky cc @cuanschutz.bsky.social @cucancercenter.bsky.social @accordsresearch.bsky.social
Mark your schedule for these #ASH24 sessions about upcoming guidelines!
#amyloidosis #lymsm #VTE #Hematology #HemeSky
#amyloidosis #lymsm #VTE #Hematology #HemeSky
December 7, 2024 at 12:00 AM
Mark your schedule for these #ASH24 sessions about upcoming guidelines!
#amyloidosis #lymsm #VTE #Hematology #HemeSky
#amyloidosis #lymsm #VTE #Hematology #HemeSky
November 16, 2024 at 8:55 AM
Excellent data with PEMBRO-GVD in relapsed #Hodgkin lymphoma in study by @mskcancercenter.bsky.social Alison Moskowitz - she will present additional data tomorrow #ash24 #lymsm
December 7, 2024 at 5:50 PM
Excellent data with PEMBRO-GVD in relapsed #Hodgkin lymphoma in study by @mskcancercenter.bsky.social Alison Moskowitz - she will present additional data tomorrow #ash24 #lymsm
On my way to @ash-hematology.bsky.social #ASH24 & sharing this starterpack for HCT, #CARTcells & #genetherapy - > 100 members DM/comment if I missed someone #bmtsm #mmsm #leusm #lymsm #sicklecell #mpnsm #medsky
go.bsky.app/7xxh8WW
go.bsky.app/7xxh8WW
December 5, 2024 at 12:32 PM
On my way to @ash-hematology.bsky.social #ASH24 & sharing this starterpack for HCT, #CARTcells & #genetherapy - > 100 members DM/comment if I missed someone #bmtsm #mmsm #leusm #lymsm #sicklecell #mpnsm #medsky
go.bsky.app/7xxh8WW
go.bsky.app/7xxh8WW
Every year this is how I feel after ASH. A final #ASHaiku
Every year it comes
ASH conference lights the path
Purpose renewed
#ASH24 #hematology #HemeSky #lymsm
Every year it comes
ASH conference lights the path
Purpose renewed
#ASH24 #hematology #HemeSky #lymsm
Are you feeling revitalized? 🎇
#ASH24 has been an incredible reminder of why we do what we do. The knowledge and inspiration gained here will undoubtedly lead to exciting advances as we return home to apply what we've learned.
Here's to a fantastic final day in San Diego!☀️ #HemeSky #Hematology
#ASH24 has been an incredible reminder of why we do what we do. The knowledge and inspiration gained here will undoubtedly lead to exciting advances as we return home to apply what we've learned.
Here's to a fantastic final day in San Diego!☀️ #HemeSky #Hematology
December 10, 2024 at 9:11 PM
Every year this is how I feel after ASH. A final #ASHaiku
Every year it comes
ASH conference lights the path
Purpose renewed
#ASH24 #hematology #HemeSky #lymsm
Every year it comes
ASH conference lights the path
Purpose renewed
#ASH24 #hematology #HemeSky #lymsm
Come join us to learn about moving CAR T-cell therapy forward in patients with lymphoma. Ongoing now at the convention center at #ASH24 @ash-hematology.bsky.social #lymsm #MedSky #OncSky
December 7, 2024 at 3:28 AM
Come join us to learn about moving CAR T-cell therapy forward in patients with lymphoma. Ongoing now at the convention center at #ASH24 @ash-hematology.bsky.social #lymsm #MedSky #OncSky
Such a beautiful energy @womeninlymphoma.bsky.social @judithtrotman.bsky.social and plans for the next WiL projects #lymsm #ASH24
December 9, 2024 at 10:41 PM
Such a beautiful energy @womeninlymphoma.bsky.social @judithtrotman.bsky.social and plans for the next WiL projects #lymsm #ASH24
Great summary table of all studies of CAR-T in CNS lymphomas (primary & secondary). #lymsm #tcellrx
www.nature.com/articles/s41...
www.nature.com/articles/s41...
January 13, 2025 at 10:51 PM
Great summary table of all studies of CAR-T in CNS lymphomas (primary & secondary). #lymsm #tcellrx
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Great work by 2 talented junior investigators. Danny Luan described immune recovery post #CARTcells (paper accepted this week!) & Marina Gomez performed dynamic landmark analysis post CD19 CAR-T #ash24 #lymsm
December 8, 2024 at 2:08 PM
Great work by 2 talented junior investigators. Danny Luan described immune recovery post #CARTcells (paper accepted this week!) & Marina Gomez performed dynamic landmark analysis post CD19 CAR-T #ash24 #lymsm
🧵 EPA has banned 2 VOCs, called TCE & perc, found in dry cleaning solution, spot removers, car paint, glues, furniture care, degreasing agents, & more. They are known to be assoc with #cancer, #Parkinsons, & stillbirth.
#OncoAlert #kcsm #leusm #lymsm #MedSky #OncSky
Link below
#OncoAlert #kcsm #leusm #lymsm #MedSky #OncSky
Link below
December 9, 2024 at 8:03 PM
🧵 EPA has banned 2 VOCs, called TCE & perc, found in dry cleaning solution, spot removers, car paint, glues, furniture care, degreasing agents, & more. They are known to be assoc with #cancer, #Parkinsons, & stillbirth.
#OncoAlert #kcsm #leusm #lymsm #MedSky #OncSky
Link below
#OncoAlert #kcsm #leusm #lymsm #MedSky #OncSky
Link below
2024 approvals: Summary of 12 new 💊indications in heme malignancies by FDA:
1. #Zanubrutinib
2. #Ponatinib
3. #LisoCel x2
4. #Imetelstat
5. #Epcortimab
6. #Daratumuab
7. #Axatilimab
8. #Isatuximab
9. #Asciminib
10. #ObiCel
11. #Revumenib
#HemeSky #OncSky #mmsm #leusm #MedSky #lymsm
1. #Zanubrutinib
2. #Ponatinib
3. #LisoCel x2
4. #Imetelstat
5. #Epcortimab
6. #Daratumuab
7. #Axatilimab
8. #Isatuximab
9. #Asciminib
10. #ObiCel
11. #Revumenib
#HemeSky #OncSky #mmsm #leusm #MedSky #lymsm
December 24, 2024 at 3:07 AM
2024 approvals: Summary of 12 new 💊indications in heme malignancies by FDA:
1. #Zanubrutinib
2. #Ponatinib
3. #LisoCel x2
4. #Imetelstat
5. #Epcortimab
6. #Daratumuab
7. #Axatilimab
8. #Isatuximab
9. #Asciminib
10. #ObiCel
11. #Revumenib
#HemeSky #OncSky #mmsm #leusm #MedSky #lymsm
1. #Zanubrutinib
2. #Ponatinib
3. #LisoCel x2
4. #Imetelstat
5. #Epcortimab
6. #Daratumuab
7. #Axatilimab
8. #Isatuximab
9. #Asciminib
10. #ObiCel
11. #Revumenib
#HemeSky #OncSky #mmsm #leusm #MedSky #lymsm
Really grateful to have had the opportunity to present a poster highlighting my work with @majorajay.bsky.social at #ASH2024 it was a great experience with a great group of people!
December 10, 2024 at 3:53 PM
Important paper: Comparing axi-cel and liso-cel in patients receiving 3L+ therapy for relapsed large b-cell lymphoma. Outcomes similar to trials, but liso-cel takes longer and when matched, axi-cel improved PFS. @oncoalert.bsky.social
#lymsm #medsky #oncsky
#lymsm #medsky #oncsky
November 19, 2024 at 10:49 PM
Important paper: Comparing axi-cel and liso-cel in patients receiving 3L+ therapy for relapsed large b-cell lymphoma. Outcomes similar to trials, but liso-cel takes longer and when matched, axi-cel improved PFS. @oncoalert.bsky.social
#lymsm #medsky #oncsky
#lymsm #medsky #oncsky
Good news for patients with #DLBCL Diffuse large B-cell #lymphoma that #epcoritamab has received a positive funding recommendation from the PBAC in Australia. #lymsm 2L Axi-Cel this week, bispecifics in the 3L soon, it seems. Good news on a Friday. #lymsm
Pharmaceutical Benefits Scheme (PBS) | PBAC Outcomes
See also
buff.ly
December 20, 2024 at 6:42 AM
Good news for patients with #DLBCL Diffuse large B-cell #lymphoma that #epcoritamab has received a positive funding recommendation from the PBAC in Australia. #lymsm 2L Axi-Cel this week, bispecifics in the 3L soon, it seems. Good news on a Friday. #lymsm
February 8, 2025 at 1:36 AM
Kendrick ain't got nothing on Dr. Kamdar, featured on the @cuanschutz.bsky.social #SuperBowlLIX ad! #lymsm
February 10, 2025 at 2:41 AM
Kendrick ain't got nothing on Dr. Kamdar, featured on the @cuanschutz.bsky.social #SuperBowlLIX ad! #lymsm
Looking forward to sharing collaborative work by myself and @dr-chromatin.bsky.social from the labs of @adrianbracken.bsky.social and @conwayer1.bsky.social at #ASH24 in San Diego this week. #hemesky #lymsm please feel free to stop by and share your thoughts.
December 5, 2024 at 7:04 PM
Looking forward to sharing collaborative work by myself and @dr-chromatin.bsky.social from the labs of @adrianbracken.bsky.social and @conwayer1.bsky.social at #ASH24 in San Diego this week. #hemesky #lymsm please feel free to stop by and share your thoughts.
STARTING SOON!
Tues 11/19/24 9:30-10:30a EST: US & EU #regulatory colleagues discuss #PedOnc & #AYACSM challenges in #cancer #DrugDevelopment.
cc @GRASPtweets @OncoAlert @ASCO @AmerAcadPeds
#leusm #sarcoma #btsm #lymsm #advocacy #OncSky #PedSky
Reg here for free: surveymonkey.com/r/5TNRXV5
Tues 11/19/24 9:30-10:30a EST: US & EU #regulatory colleagues discuss #PedOnc & #AYACSM challenges in #cancer #DrugDevelopment.
cc @GRASPtweets @OncoAlert @ASCO @AmerAcadPeds
#leusm #sarcoma #btsm #lymsm #advocacy #OncSky #PedSky
Reg here for free: surveymonkey.com/r/5TNRXV5
November 19, 2024 at 2:10 PM
STARTING SOON!
Tues 11/19/24 9:30-10:30a EST: US & EU #regulatory colleagues discuss #PedOnc & #AYACSM challenges in #cancer #DrugDevelopment.
cc @GRASPtweets @OncoAlert @ASCO @AmerAcadPeds
#leusm #sarcoma #btsm #lymsm #advocacy #OncSky #PedSky
Reg here for free: surveymonkey.com/r/5TNRXV5
Tues 11/19/24 9:30-10:30a EST: US & EU #regulatory colleagues discuss #PedOnc & #AYACSM challenges in #cancer #DrugDevelopment.
cc @GRASPtweets @OncoAlert @ASCO @AmerAcadPeds
#leusm #sarcoma #btsm #lymsm #advocacy #OncSky #PedSky
Reg here for free: surveymonkey.com/r/5TNRXV5
⚕️ @womeninlymphoma.bsky.social Steering Committee members, advocates, sponsors and supporters from all over the world 🌍 networking and sharing connections, initiatives and experience at #ASH24
#lymsm #lymphoma @ash-hematology.bsky.social
#lymsm #lymphoma @ash-hematology.bsky.social
December 9, 2024 at 11:49 PM
⚕️ @womeninlymphoma.bsky.social Steering Committee members, advocates, sponsors and supporters from all over the world 🌍 networking and sharing connections, initiatives and experience at #ASH24
#lymsm #lymphoma @ash-hematology.bsky.social
#lymsm #lymphoma @ash-hematology.bsky.social
Can't congratulate Dr. Allen enough on her #ASH24 abstract; keep your eyes peeled for a manuscript in 2025! And the whole @cuanschutz.bsky.social internal med gang showed up, too! #ASHKudos #lymsm cc @jessicaallenmd.bsky.social @vpizzuti.bsky.social
December 8, 2024 at 2:11 AM
Can't congratulate Dr. Allen enough on her #ASH24 abstract; keep your eyes peeled for a manuscript in 2025! And the whole @cuanschutz.bsky.social internal med gang showed up, too! #ASHKudos #lymsm cc @jessicaallenmd.bsky.social @vpizzuti.bsky.social
June 17, 2025 at 1:30 PM